---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-029943"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2026-06-24T21:00:31+00:00"
generated_at: "2026-06-24T21:03:26.224550+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics shareholders approve increase in authorized common shares from 300M to 400M

## Summary
- Amendment approved: 152,941,468 for, 12,113,250 against, 382,419 abstain; effective June 24, 2026.
- All three Class B director nominees re-elected: James L. Cox, John R. Palumbo, Ronald M. Sparks.
- Ratification of CBIZ CPAs P.C. as independent auditor for FY 2025 approved (161.8M votes for).
- Approximately 84.7% of outstanding shares represented at the annual meeting.

## SEC filing metadata
- accession: 0001493152-26-029943
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2026-06-24T21:00:31+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315226029943/0001493152-26-029943-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315226029943/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-029943
- JSON: https://secwatch.observer/filing/0001493152-26-029943.json
- Plain text: https://secwatch.observer/filing/0001493152-26-029943.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.